Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 203649
Company: SANDOZ
Company: SANDOZ
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| TREPROSTINIL | TREPROSTINIL | 1MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | AP | No | No |
| TREPROSTINIL | TREPROSTINIL | 2.5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | AP | No | No |
| TREPROSTINIL | TREPROSTINIL | 5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | AP | No | No |
| TREPROSTINIL | TREPROSTINIL | 10MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
| Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
|---|---|---|---|---|---|---|---|
| 11/30/2017 | ORIG-1 | Approval |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203649Orig1s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/203649Orig1s000ltr.pdf |
Supplements
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
|---|---|---|---|---|---|
| 03/14/2024 | SUPPL-10 | Labeling-Package Insert |
Label is not available on this site. |
||
| 11/20/2018 | SUPPL-5 | Labeling-Package Insert |
Label is not available on this site. |
||
| 11/20/2018 | SUPPL-4 | Labeling-Package Insert, Labeling-Medication Guide |
Label is not available on this site. |
||
| 11/20/2018 | SUPPL-2 | Labeling-Package Insert, Labeling-Container/Carton Labels |
Label is not available on this site. |
||
| 04/18/2018 | SUPPL-1 | Labeling-Package Insert |
Label is not available on this site. |
| Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
|---|---|---|---|---|---|
| 11/30/2017 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/203649Orig1s000lbl.pdf |
TREPROSTINIL
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS; 1MG/ML
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| REMODULIN | TREPROSTINIL | 1MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | Yes | AP | 021272 | UNITED THERAP |
| TREPROSTINIL | TREPROSTINIL | 1MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 211574 | ALEMBIC GLOBAL |
| TREPROSTINIL | TREPROSTINIL | 1MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 210214 | DR REDDYS |
| TREPROSTINIL | TREPROSTINIL | 1MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 203649 | SANDOZ |
| TREPROSTINIL | TREPROSTINIL | 1MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 206648 | TEVA PHARMS USA |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS; 2.5MG/ML
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| REMODULIN | TREPROSTINIL | 2.5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | Yes | AP | 021272 | UNITED THERAP |
| TREPROSTINIL | TREPROSTINIL | 2.5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 211574 | ALEMBIC GLOBAL |
| TREPROSTINIL | TREPROSTINIL | 2.5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 210214 | DR REDDYS |
| TREPROSTINIL | TREPROSTINIL | 2.5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 203649 | SANDOZ |
| TREPROSTINIL | TREPROSTINIL | 2.5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 206648 | TEVA PHARMS USA |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS; 5MG/ML
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| REMODULIN | TREPROSTINIL | 5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | Yes | AP | 021272 | UNITED THERAP |
| TREPROSTINIL | TREPROSTINIL | 5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 211574 | ALEMBIC GLOBAL |
| TREPROSTINIL | TREPROSTINIL | 5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 210214 | DR REDDYS |
| TREPROSTINIL | TREPROSTINIL | 5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 203649 | SANDOZ |
| TREPROSTINIL | TREPROSTINIL | 5MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 206648 | TEVA PHARMS USA |
INJECTABLE;INTRAVENOUS, SUBCUTANEOUS; 10MG/ML
TE Code = AP
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
|---|---|---|---|---|---|---|---|---|
| REMODULIN | TREPROSTINIL | 10MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | Yes | AP | 021272 | UNITED THERAP |
| TREPROSTINIL | TREPROSTINIL | 10MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 211574 | ALEMBIC GLOBAL |
| TREPROSTINIL | TREPROSTINIL | 10MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 210214 | DR REDDYS |
| TREPROSTINIL | TREPROSTINIL | 10MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 203649 | SANDOZ |
| TREPROSTINIL | TREPROSTINIL | 10MG/ML | INJECTABLE;INTRAVENOUS, SUBCUTANEOUS | Prescription | No | AP | 206648 | TEVA PHARMS USA |